Hosp. El Bierzo

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Bipolar disorder1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed3 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Janssen Pharmaceutica N.V., Belgium1 trial

Closed trials

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Completed

  A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05455684· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Janssen Pharmaceutica N.V., Belgium· Source